Perioperative outcomes of cardiac surgery patients with ongoing ticagrelor therapy: Boon and bane of a new drug

European Journal of Cardio-thoracic Surgery

Volumn 46, Issue 2, 2014, Pages 198-205

  Schotola, Hanna ^a   Bräuer, Anselm ^a   Meyer, Katharina ^a   Hinz, José ^a   Schöndube, Friedrich Albert ^a   Bauer, Martin ^a   Mohite, Prashant Nanasaheb ^b   Danner, Bernd Christoph ^a   Sossalla, Samuel ^a   Popov, Aron Frederik ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

CABG; Continued ticagrelor application; Perioperative outcome

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ENOXAPARIN; FIBRINOGEN; HEPARIN; PHENPROCOUMON; PROTHROMBIN COMPLEX; TICAGRELOR; ADENOSINE; ANTITHROMBOCYTIC AGENT;

ACUTE KIDNEY FAILURE; AGED; ANEURYSM SURGERY; ANTICOAGULANT THERAPY; AORTA VALVE REPLACEMENT; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CELL COUNT; BLOOD CLOTTING TIME; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DYSLIPIDEMIA; ERYTHROCYTE TRANSFUSION; EUROSCORE; FEMALE; HEART SURGERY; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPAIR; MORTALITY; OBSERVATIONAL STUDY; OPERATION DURATION; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; STENT THROMBOSIS; SURGICAL PATIENT; THORACOTOMY; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; ANALOGS AND DERIVATIVES; BLEEDING; BLOOD TRANSFUSION; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; VERY ELDERLY;

ADENOSINE; AGED; AGED, 80 AND OVER; ASPIRIN; BLOOD TRANSFUSION; CORONARY ARTERY BYPASS; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PERIOPERATIVE PERIOD; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84905489997     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezt571     Document Type: Article

References (25)

1. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-57.
2. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
3. Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of The European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
4. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions. Circulation 2011;124:2574-609.
5. Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: Results from the premier registry. Circulation 2006;113:2803-9.
6. Ng CS, Wan S, Yim AP, Arifi AA. Pulmonary dysfunction after cardiac surgery. Chest 2002;121:1269-77.
7. Shaw A. Update on acute kidney injury after cardiac surgery. J Thorac Cardiovasc Surg 2012;143:676-81.
8. Badreldin A, Kroener A, Kamiya H, Lichtenberg A, Hekmat K. Effect of clopidogrel on perioperative blood loss and transfusion in coronary artery bypass graft surgery. Interact CardioVasc Thorac Surg 2010;10:48-52.
9. Herman CR, Buth KJ, Kent BA, Hirsch GM. Clopidogrel increases blood transfusion and hemorrhagic complications in patients undergoing cardiac surgery. Ann Thorac Surg 2010;89:397-402.
10. Held C, Asenblad N, Bassand JP, Becker RC, Cannon CP, Claeys MJ et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol 2011;57:672-84.
11. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, Boden WE et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006;354:1706-17.
12. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (Caprie). Caprie steering committee. Lancet 1996;348: 1329-39.
13. Di Dedda U, Ranucci M, Baryshnikova E, Castelvecchio S. Thienopyridines resistance and recovery of platelet function after discontinuation of thienopyridines in cardiac surgery patients. Eur J Cardiothorac Surg 2014;45: 165-70.
14. Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999;15:816-22.
15. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279:1477-82.
16. Kaptoge S, Di Angelantonio E, Pennells L, Wood AM, White IR, Gao P et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012;367:1310-20.
17. Mobley JE, Bresee SJ, Wortham DC, Craft RM, Snider CC, Carroll RC. Frequency of nonresponse antiplatelet activity of clopidogrel during pretreatment for cardiac catheterization. Am J Cardiol 2004;93:456-8.
18. Lee JM, Park S, Shin DJ, ChoiD, ShimCY, Ko YGet al. Relation of genetic polymorphisms in the cytochrome p450 gene with clopidogrel resistance after drug-eluting stent implantation in Koreans. AmJ Cardiol 2009;104:46-51.
19. Karkouti K, Wijeysundera DN, Yau TM, Beattie WS, Abdelnaem E, McCluskey SA et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004;44:1453-62.
20. Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD et al. Morbidity and mortality risk associated with red blood cell and bloodcomponent transfusion in isolated coronary artery bypass grafting. Crit Care Med 2006;34:1608-16.
21. Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM et al. Transfusion-related acute lung injury: definition and review. Crit Care Med 2005;33:721-6.
22. Uji M, Terada Y, Noguchi T, Nishida T, Hasuwa K, Shinohara K et al. [Perioperative fibrinogen concentrations in cardiac surgery with cardiopulmonary bypass]. Masui 2012;61:814-9.
23. Ranucci M, Baryshnikova E, Soro G, Ballotta A, De Benedetti D, Conti D. Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. Ann Thorac Surg 2011;91: 123-9.
24. Gorlinger K, Dirkmann D, Hanke AA, Kamler M, Kottenberg E, Thielmann M et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, singlecenter cohort study. Anesthesiology 2011;115:1179-91.
25. Weber CF, Gorlinger K, Meininger D, Herrmann E, Bingold T, Moritz A et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012;117: 531-47.